✦ LIBER ✦

Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer

✍ Scribed by Hideyuki Harada; Nobuyuki Yamamoto; Toshiaki Takahashi; Masahiro Endo; Haruyasu Murakami; Asuka Tsuya; Yukiko Nakamura; Akira Ono; Satoshi Igawa; Takehito Shukuya; Akihiro Tamiya; Tetsuo Nishimura

Publisher: Springer
Year: 2009
Tongue: English
Weight: 249 KB
Volume: 14
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-009-0907-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preoperative concurrent chemoradiotherap

Preoperative concurrent chemoradiotherapy for unresectable stage III nonsmall cell lung cancer

✍ David Milstein; Abraham Kuten; Milton Saute; A.E.L.A. Best; Khalid Daoud; Issam 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 770 KB

Hypofractionated radiation therapy in un

Hypofractionated radiation therapy in unresectable stage iii non-small cell lung cancer

✍ B. J. Slotman; K. H. Njo; A. De Jonge; O. W. M. Meijer; A. B. M. F. Karim 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 769 KB

Perioperative chemotherapy of stage III

Perioperative chemotherapy of stage III N2 non-small cell lung cancer

✍ Yongfeng Yu; Shun Lu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 161 KB

Concurrent chemoradiotherapy in limited-

Concurrent chemoradiotherapy in limited-stage small-cell lung cancer. Results of a pilot study

✍ A. Radkowski; S. Korzeniowski; B. Sas-Korczyńska; K. Malecki; J. Skołyszewski 📂 Article 📅 1999 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 504 KB

Phase 2 study of high-dose proton therap

Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer

✍ Joe Y. Chang; Ritsuko Komaki; Charles Lu; Hong Y. Wen; Pamela K. Allen; Anne Tsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

Induction chemotherapy for stage IIIA un

Induction chemotherapy for stage IIIA unresectable non-small cell lung cancer: The toronto experience and an overview

✍ Melvyn Goldberg; Ronald L. Burkes 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Thirty-nine patients with mediastinoscopy stage IIIA, N2 non-small cell lung cancer received two cycles of MVP (mitomycin C, vindesine, cisplatin). Responders underwent thoracotomy for resection and two further courses of MVP. Overall response rate was 64% (25/39) with three complete and 22 partial